Replimune Group, Inc. (REPL)
Recommendation: buy
PE: N/A
Previous close: 13.26
$14.12 USD
+6.49% change today
+17.67% change last month
5D 1M 6M 1Y
Average analyst target: 16.5
Healthcare, Biotechnology
Market cap: 966.05MRecommendation: buy
PE: N/A
Previous close: 13.26
$14.12 USD
+6.49% change today
+17.67% change last month
5D 1M 6M 1Y
Inversely correlated stocks:
MVF VTMX GFL More >>More data :
Price-to-book : 2.53Average analyst target: 16.5